Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Purple Biotech Ltd. Sponsored ADR (PPBT) had Cash Flow from Financial Activities of $2.05M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$0.44M |
|
-- |
|
-- |
|
$1.30M |
|
$-1.30M |
|
$1.74M |
|
$0.44M |
|
$0.44M |
|
$0.44M |
|
$0.44M |
|
$0.44M |
|
$0.44M |
|
$-1.30M |
|
$-1.23M |
|
1.09M |
|
1.09M |
|
$0.41 |
|
$0.41 |
|
| Balance Sheet Financials | |
$6.59M |
|
$0.12M |
|
$7.58M |
|
$14.17M |
|
$1.78M |
|
-- |
|
$0.17M |
|
$1.95M |
|
$12.21M |
|
$4.85M |
|
$12.21M |
|
-- |
|
| Cash Flow Statement Financials | |
$-5.62M |
|
$0.05M |
|
|
Cash Flow from Financial Activities |
$2.05M |
$8.72M |
|
$5.24M |
|
$-3.48M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
3.61% |
|
9.09% |
|
3.11% |
|
3.61% |
|
-- |
|
$-5.18 |
|
$-5.18 |
|